Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques
References (23)
- et al.
Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase
Biochim. Biophys. Acta
(2002) - et al.
Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers: a new approach for the molecular analysis of paraffin-embedded cancer tissue
Am. J. Pathol.
(2001) - et al.
Predictive factors of disease-free survival for nonmetastatic osteosarcoma of the extremity: An analysis of 303 patients treated at the Rizzoli Institute
Ann. Oncol.
(2001) - et al.
DNA copy number losses in human neoplasms
Am. J. Pathol.
(1999) - et al.
Simultaneous paired analysis of numerical chromosomal aberrations and DNA content in osteosarcoma
Mod. Pathol.
(2001) - et al.
Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA to poisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992
Br. J. Haematol.
(2001) - et al.
Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Rizzoli/osteosarcoma-2 protocol: an updated report
J. Clin. Oncol.
(2000) - et al.
Local and systemic control for osteosarcoma of the extremity treated with neoadjuvant chemotherapy and limb salvage surgery: the Rizzoli experience
Oncol. Rep.
(2001) - et al.
Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas
Genes Chromosomes Cancer
(2003) - et al.
Resistance mechanisms to methotrexate in tumours
Stem Cells
(1996)
The role of chemotherapy in the management of non-metastatic operable extremity osteosarcoma
Semin. Oncol.
(1997)
Cited by (0)
Copyright © 2003 Urban & Fischer Verlag. Published by Elsevier GmbH All rights reserved.